The ViroKey SQ FLEX SARS-CoV-2 Genotyping Assay is a next-generation sequencing (NGS)-based test intended for the detection of genomic mutations of the SARS-CoV-2 RNA genome from nasopharyngeal or oropharyngeal swab samples to support molecular epidemiology of SARS-CoV-2 research.
The ViroKey SQ FLEX SARS-CoV-2 Genotyping Assay is used in conjunction with the Sentosa® SX U-Prep Kit as well as the Sentosa SQ Virus Testing Solutions on the Sentosa SX101, Sentosa ST401 and Sentosa SQ301 instruments.
High Performance and Robustness:
Providing Laboratory Efficiency and Effectiveness:
Parameters | Specification |
Sample Types |
Nasopharyngeal and Oropharyngeal Swabs in UTM/VTM or PBS/Liquid Amies/Saline |
Sample Input |
730 μL |
Sample Throughput |
Up to 15 samples per run |
Controls |
System Control, Extraction Control, Positive Control (Optional) |
Coverage |
≥ 200X |
Limit of Detection (LoD) |
1000 GE/mL |
Hands-on Time |
< 2 hours |
Turnaround Time |
~2 days (from sample to results) |
Product | Pack Size | Item Number |
---|---|---|
Sentosa SQ Virus Testing Solutions (4x24) RUO | 4x24 | 300775 |
Sentosa SX U-Prep Kit (4) RUO | 4 | 300836 |
ViroKey SQ FLEX Library Prep Reagents (4x16) RUO | 4x16 | 300823 |
ViroKey SQ FLEX SARS-CoV-2 Primer Set (96) RUO | 96 | 301091 |
ViroKey SQ SARS-CoV-2 Positive Control Kit (8) RUO | 8 | 301092 |